Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator
- 30 April 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 92 (4) , 384-390
- https://doi.org/10.1016/0002-9343(92)90268-g
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Coronary Thrombolysis: Streptokinase or Recombinant Tissue-Type Plasminogen Activator?Annals of Internal Medicine, 1990
- Tissue Plasminogen ActivatorNew England Journal of Medicine, 1988
- Intracerebral Hemorrhage Complicating Intravenous Tissue Plasminogen Activator TreatmentArchives of Neurology, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1987
- Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1987
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Thrombolytic therapy in the eightiesBlood, 1986